Foster and Thrive Maximum Strength Urinary Pain Relief PHENAZOPYRIDINE HYDROCHLORIDE 99.5 mg Tablet, 12-count
by Strategic Sourcing Services LLC · 1 BLISTER PACK in 1 CARTON (70677-1230-1) / 12 TABLET in 1 BLISTER PACK
NDC 70677-1230-01
🏷️ FDA NDC (as labeled)
70677-1230-1
billing pads the package segment with a zero
OTC
On market
Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →
🆔 Identity & classification
FDA NDC (as labeled)
70677-1230-1
Product NDC
70677-1230
11-digit billing NDC
70677123001
NCPDP billing unit
EA — each (per item)
RxCUI
1094147
UNII
0EWG668W17
SPL Set ID
97ea2a3e-c1a0-437d-ac2a-2128e193183b
DEA schedule
Non-controlled
Marketing category
UNAPPROVED DRUG OTHER
Marketing status
On market
FDA listing status
Listed (active directory)
Marketing start
2023-07-20
Route
ORAL
Dosage form
TABLET
Substance
PHENAZOPYRIDINE HYDROCHLORIDE
GPI-14
56300010100353
GCN Seq No
079502
GCN
46004
HICL code
004108
Ingredient (HICL)
Phenazopyridine Hcl
HIC1 code
R
Therapeutic class — broad (HIC1)
Kidney/Urinary Tract
HIC2 code
R5
Therapeutic class — intermediate (HIC2)
Urinary Tract Anesthetic/Analgesic Agents
HIC3 code
R5A
Therapeutic class — specific (HIC3)
Urinary Tract Anesthetic/Analgesic Agnt (Azo-Dye)
AHFS code
84:08.00.00
AHFS class
Antipruritics And Local Anesthetics
FDB label name
FT URINARY PAIN RLF 99.5 MG TB
FDB brand name
Urinary Pain Relief
Legend status
O — Over-the-counter (OTC) drug or device
Why two NDCs?
The FDA registers this code as 70677-1230-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 70677-1230-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.
🏷️ RxNorm drug class
This medicine belongs to the Other urologicals class.
Drug family (ATC)
Other urologicals
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.
🏭 Manufacturer & labeler
LabelerStrategic Sourcing Services LLC
Labeler code70677
First marketedJul 2023
Product typeHuman Otc Drug
Portfolio316 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.
🩺 Clinical
Label name FT URINARY PAIN RLF 99.5 MG TB Ingredient Phenazopyridine Hcl
📗 Our plain-language guide HelloPharmacist
- It only helps with the pain — it doesn't kill the bacteria causing the infection. Think of it as taking the edge off while your antibiotic does the real work. If you have a UTI, yo...
- Does phenazopyridine actually treat my UTI, or does it just help with the pain?
- That's completely expected with phenazopyridine — it's one of the most common things people notice. The drug itself has an orange-red dye, and it passes into your urine, which is w...
- Why is my urine turning orange or red? Should I be worried?
Patient education
Supplement & herbal interactions
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.
💬 Questions about PHENAZOPYRIDINE HYDROCHLORIDE?
Ask a pharmacist →
Ask a licensed pharmacist directly — free, answered by our team.
🧪 Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.
💲 Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per ea | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | $0.184 | $2.21 / 12 tablets |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
NADAC price history (per ea) — tap or hover for the price & month
▲ Up 5% over the last 10 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.
🔁 Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Good Neighbor Maximum Strength Urinary Pain Relief 99.5 mg 46122-0628-53 | AmerisourceBergen | 12 tablets | $0.184 | — | Availability likely | — |
| URO-PAIN Maximum Strength 99.5 mg 57237-0330-21 | Rising | 12 tablets | $0.184 | — | Availability likely | — |
| Leader Maximum Strength Urinary Pain Relief 99.5 mg 70000-0523-01 | Cardinal | 12 tablets | $0.184 | — | Availability likely | — |
| Foster and Thrive Maximum Strength Urinary Pain Relief 99.5 mgthis 70677-1230-01 | Strategic | 12 tablets | $0.184 | — | Availability likely | — |
| HealthMart Maximum Strength Urinary Pain Relief 99.5 mg 62011-0412-01 | Strategic | 12 tablets | $0.186 | — | FDA listed | +1% |
| Sunmark Maximum Strength Urinary Pain Relief 99.5 mg 70677-0078-01 | Strategic | 12 tablets | $0.186 | — | FDA listed | +1% |
| Wallgreens Maximum Strength Urinary Pain Relief 99.5 mg 00363-8455-12 | Walgreens | 12 tablets | — | — | FDA listed | — |
| Preferred Maximum Strength Urinary Pain Relief 99.5 mg 10956-0210-12 | Reese | 12 tablets | — | — | FDA listed | — |
| Vexia Maximum Strength Urinary Pain Relief 99.5 mg 10956-0703-24 | Reese | 24 tablets | — | — | FDA listed | — |
| Maximum Strength Urinary Pain Relief 99.5 mg 11673-0270-24 | TARGET | 24 tablets | — | — | FDA listed | — |
| Rite Aid Maximum Strength Urinary Pain Relief 99.5 mg 11822-3111-02 | Rite | 12 tablets | — | — | FDA listed | — |
| Signature Care Maximum Strength Urinary Pain Relief 99.5 mg 21130-0792-24 | Safeway | 24 tablets | — | — | FDA listed | — |
| Kroger Maximum Strength Urinary Pain Relief 99.5 mg 30142-0221-24 | THE | 24 tablets | — | — | FDA listed | — |
| Maximum Strength Urinary Pain Relief 99.5 mg 30142-0756-24 | KROGER | 24 tablets | — | — | FDA listed | — |
| TopCare Maximum Strength Urinary Pain Relief 99.5 mg 36800-0510-12 | TOPCO | 12 tablets | — | — | FDA listed | — |
| Meijer Maximum Strength Urinary Pain Relief 99.5 mg 41250-0342-12 | Meijer | 12 tablets | — | — | FDA listed | — |
| Walmart Maximum Strength Urinary Pain Relief 99.5 mg 49035-0297-12 | Walmart | 12 tablets | — | — | FDA listed | — |
| AZO Urinary Pain Relief Maximum Strength 99.5 mg 49973-0247-12 | i-Health, | 12 tablets | — | — | FDA listed | — |
| Phenazopyridine Hydrochloride 99.5 mg 50696-0003-01 | GPT | 25000 tablets | — | — | FDA listed | — |
| Uricalm Maximum Strength 99.5 mg 52389-0241-24 | Kobayashi | 24 tablets | — | — | FDA listed | — |
| Discount Drugmart Maximum Strength Urinary Pain Relief 99.5 mg 53943-0336-12 | Discount | 12 tablets | — | — | FDA listed | — |
| Family Dollar Maximum Strength Urinary Pain Relief 99.5 mg 55319-0211-12 | Family | 12 tablets | — | — | FDA listed | — |
| Dollar General Maximum Strength Urinary Pain Relief 99.5 mg 55910-0631-12 | Dolgencorp, | 12 tablets | — | — | FDA listed | — |
| Uristat Ultra 99.5 mg 63029-0105-12 | Medtech | 12 tablets | — | — | FDA listed | — |
| Monistat Maintain 99.5 mg 63736-0020-12 | Insight | 12 tablets | — | — | FDA listed | — |
| Quality Choice Maximum Strength Urinary Pain Relief 99.5 mg 63868-0297-12 | Chain | 12 tablets | — | — | FDA listed | — |
| Premier Value Maximum Strength Urinary Pain Relief 99.5 mg 68016-0129-12 | Chain | 12 tablets | — | — | FDA listed | — |
| Preferred Maximum Strength Urinary Pain Relief 99.5 mg 68788-7778-01 | Preferred | 12 tablets | — | — | Discontinued | — |
| Harris Teeter Maximum Strength Urinary Pain Relief 99.5 mg 69256-0767-12 | Harris | 12 tablets | — | — | FDA listed | — |
| Cystex Max UTI Pain Relief 99.5 mg 69693-0514-24 | Clarion | 24 tablets | — | — | FDA listed | — |
| CVS Maximum Strength Urinary Pain Relief 99.5 mg 69842-0713-12 | CVS | 12 tablets | — | — | FDA listed | — |
| RIGHT REMEDIES Maximum Strength Urinary Pain Relief 99.5 mg 70692-0163-39 | Strive | 72 tablets | — | — | FDA listed | — |
| GOOD REMEDIES Maximum Strength Urinary Pain Relief Caplet 99.5 mg 70692-0178-08 | Strive | 8 tablets | — | — | FDA listed | — |
| Care One Maximum Strength Urinary Pain Relief 99.5 mg 72476-0210-12 | Retail | 12 tablets | — | — | FDA listed | — |
| Uti Pain Relief 99.5 mg 73436-2441-02 | Cadence | 12 tablets | — | — | FDA listed | — |
| Urinary Pain Relief 99.5 mg 73581-0909-72 | YYBA | 72 tablets | — | — | Discontinued | — |
| Urinary Pain Relief 99.5 mg 73581-0919-12 | YYBA | 120 tablets | — | — | FDA listed | — |
| Uqora Maximum UTI Pain Relief 99.5 mg 73712-0114-12 | Bonafide | 12 tablets | — | — | FDA listed | — |
| Maximum Strength Urinary Pain Relief 99.5 mg 80513-0517-72 | Advanced | 72 tablets | — | — | FDA listed | — |
| Stix Maximum Strength Urinary Pain Relief 99.5 mg 80584-0113-24 | Get | 24 tablets | — | — | FDA listed | — |
| Cheeky Bonsai UTI Pain Relief 99.5 mg 81860-0113-24 | IXXA, | 24 tablets | — | — | FDA listed | — |
| Quality Choice Maximum Strength Urinary Pain Relief 99.5 mg 83324-0199-12 | Chain | 12 tablets | — | — | FDA listed | — |
| Gencare-Urinary Pain Relief Maximum Strength 99.5 mg 72090-0072-01 | Pioneer | 72 tablets | — | — | FDA listed | — |
| Nuvicare-Urinary Pain Relief Maximum Strength 99.5 mg 84324-0042-01 | NUVICARE | 24 tablets | — | — | FDA listed | — |
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.
⏳ Availability & generic status
🏛️
2023
On the market since
Jul 2023
📍
2026
Currently FDA-listed
3 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.
🔬 Reported adverse events (FAERS)
Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Foster and Thrive Maximum Strength Urinary Pain Relief (this brand).
Top reported reactions
Age at onset
Reporter sex
Male · 25%
Female · 75%
Serious outcomes
Reports over time (by year) — tap or hover for the count & year
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
📦 Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Status |
|---|---|---|---|
| 70677-1230-01 You're viewing this | 1 BLISTER PACK in 1 CARTON (70677-1230-1) / 12 TABLET in 1 BLISTER PACK | 2023-07-20 | Active |
🧭 About this NDC listing & data coverage
Over-the-counter (OTC) product
Marketed without an FDA application
Listed without an FDA application
This product's marketing category indicates it is marketed without an approved FDA application (no NDA, ANDA, or BLA on file). Having an NDC does not by itself establish FDA approval — the NDC Directory is a listing system, not an approval decision. Approval-linked data such as Orange Book therapeutic-equivalence ratings therefore does not apply.
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | — Not published for this NDC No photo available yet for this listing. |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | ✓ Available |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.
Questions about this listing
Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Drug Other". Products approved under an application carry an NDA, ANDA, or BLA number.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 70677-1230-1, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 70677-1230-01, written without dashes as 70677123001. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 70677-1230-01, the first segment (70677) is the labeler code FDA assigned to Strategic Sourcing Services LLC; the middle segment (1230) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (01) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Strategic Sourcing Services LLC. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
Strategic Sourcing Services LLC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
📄 FDA label — Drug Facts FDA SPL
The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage
⏱️ Dosage and Administration
⚠️ Warnings
🧪 Active Ingredient
🧪 Inactive Ingredients
🎯 Purpose
🎯 Indications and Usage ▾
Use Fast relief from urinary pain, burning, urgency and frequency associated with urinary tract infections.
⏱️ Dosage and Administration ▾
Directions ■ adults and children 12 years and over: take 2 tablets 3 times daily with a full glass of water, with or after meals as needed ■ children under 12 years: consult a doctor ■ Do not use for more than 2 days (12 tablets) without consulting a doctor image of carton
⚠️ Warnings ▾
Warnings Do not exceed recommended dosage Do not use if you have Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency unless approved by your physician
🧪 Active Ingredient ▾
Active ingredient (in each tablet) Phenazopyridine Hydrochloride 99.5 mg .
🧪 Inactive Ingredients ▾
Inactive ingredients corn starch, croscarmellose sodium, hypromellose, lactose, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinylpyrrolidone, pregelatinized starch, silicon dioxide, sodium starch glycolate, talc and triacetin
🎯 Purpose ▾
Purpose Urinary Analgesic
No label section mentions that — try another word, or open the full label on DailyMed below.
Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA.
Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published
NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.